OncoSec Medical, Inc. (ONCSQ)
0.0000
0.00 (0.00%)
USD |
OTCM |
Aug 24, 16:00
OncoSec Medical Debt to Equity Ratio
Debt to Equity Ratio Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| January 31, 2023 | -0.6314 |
| October 31, 2022 | -5.234 |
| July 31, 2022 | 1.009 |
| April 30, 2022 | 0.4044 |
| January 31, 2022 | 0.3148 |
| October 31, 2021 | 0.2379 |
| July 31, 2021 | 0.1922 |
| April 30, 2021 | 0.133 |
| January 31, 2021 | 0.1588 |
| October 31, 2020 | 0.4869 |
| July 31, 2020 | 0.5641 |
| April 30, 2020 | 0.3468 |
| January 31, 2020 | 2.132 |
| October 31, 2019 | 0.118 |
| July 31, 2019 | 0.0035 |
| April 30, 2019 | 0.0078 |
| January 31, 2019 | 0.00 |
| October 31, 2018 | 0.00 |
| July 31, 2018 | 0.00 |
| April 30, 2018 | 0.00 |
| January 31, 2018 | 0.00 |
| October 31, 2017 | 0.00 |
| July 31, 2017 | 0.00 |
| April 30, 2017 | 0.00 |
| January 31, 2017 | 0.00 |
| Date | Value |
|---|---|
| October 31, 2016 | 0.00 |
| July 31, 2016 | 0.00 |
| April 30, 2016 | 0.00 |
| January 31, 2016 | 0.00 |
| October 31, 2015 | 0.00 |
| July 31, 2015 | 0.00 |
| April 30, 2015 | 0.00 |
| January 31, 2015 | 0.00 |
| October 31, 2014 | 0.00 |
| July 31, 2014 | 0.00 |
| April 30, 2014 | 0.00 |
| January 31, 2014 | 0.00 |
| October 31, 2013 | 0.0652 |
| July 31, 2013 | 0.00 |
| April 30, 2013 | 0.3085 |
| January 31, 2013 | 0.243 |
| October 31, 2012 | 0.7164 |
| July 31, 2012 | 0.00 |
| April 30, 2012 | 0.4074 |
| January 31, 2012 | -1.182 |
| October 31, 2011 | 3.989 |
| July 31, 2011 | 0.00 |
| April 30, 2011 | 0.00 |
| January 31, 2011 | 0.00 |
| October 31, 2010 | 0.00 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Debt to Equity Ratio Benchmarks
| ACADIA Pharmaceuticals, Inc. | 0.0565 |
| Alnylam Pharmaceuticals, Inc. | 2.206 |
| Anika Therapeutics, Inc. | 0.1839 |
| Savara, Inc. | 0.2117 |
| Vericel Corp. | 0.2556 |